| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 557 |
| 1 | METHOTREXATE SODIUM | 486 |
| 2 | METHOTREXATE | 449 |
| 3 | ETANERCEPT | 350 |
| 4 | SECUKINUMAB | 332 |
| 5 | INFLIXIMAB | 307 |
| 6 | PREDNISONE | 226 |
| 7 | FOLIC ACID | 200 |
| 8 | GOLIMUMAB | 170 |
| 9 | PREDNISOLONE | 166 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 84 | 0.0244 |
| 1 | GOLIMUMAB | 170 | 0.0135 |
| 2 | METEX | 4 | 0.0106 |
| 3 | XYLOMETAZOLINE HYDROCHLORIDE | 6 | 0.0106 |
| 4 | ABACAVIR AND LAMIVUDINE | 2 | 0.0100 |
| 5 | THYROTROPIN ALFA | 9 | 0.0087 |
| 6 | SODIUM HYALURONATE | 7 | 0.0085 |
| 7 | BEPOTASTINE BESILATE | 5 | 0.0078 |
| 8 | ACID REDUCER | 2 | 0.0077 |
| 9 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 32 | 0.0070 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 1034 |
| 1 | Corticosteroid [EPC] | 613 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 458 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 450 |
| 4 | Interleukin-17A Antagonist [EPC] | 359 |
| 5 | Vitamin C [EPC] | 235 |
| 6 | Vitamin B12 [EPC] | 214 |
| 7 | Proton Pump Inhibitor [EPC] | 211 |
| 8 | Vitamin D [EPC] | 210 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 177 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 10 | 0.0145 |
| 1 | Interleukin-17A Antagonist [EPC] | 359 | 0.0096 |
| 2 | Thyroid Stimulating Hormone [EPC] | 9 | 0.0087 |
| 3 | Melanocortin 4 Receptor Agonist [EPC] | 2 | 0.0070 |
| 4 | Antiseptic [EPC] | 24 | 0.0055 |
| 5 | Provitamin D2 Compound [EPC] | 150 | 0.0050 |
| 6 | Plasma Kallikrein Inhibitor [EPC] | 11 | 0.0046 |
| 7 | CD3-directed Antibody [EPC] | 3 | 0.0042 |
| 8 | Medium-chain Triglyceride [EPC] | 2 | 0.0036 |
| 9 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 43 | 0.0032 |